Current Cancer Drug Targets logo Bentham Science Publishers logo

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Related content
Volume 8, Number 5, August 2008

< previous issue | all issues | next issue >

Articles

FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer
pp. 342-348(7)
Authors: Cortinovis, D. L.; Andriani, F.; Livio, A.; Fabbri, A.; Perrone, F.; Marcomini, B.; Pilotti, S.; Mariani, L.; Bidoli, P.; Bajetta, E.; Roz, L.; Sozzi, G.

Targeting Angiogenesis in Renal Cell Carcinoma
pp. 349-358(10)
Authors: Lainakis, Georgios; Bamias, Aristotle

Molecular Targets in Gastrointestinal Stromal Tumors (GIST) Therapy
pp. 359-366(8)
Authors: Braconi, C.; Bracci, R.; Cellerino, R.

Regulation of Cell Growth by Estrogen Signaling and Potential Targets in Thyroid Cancer
pp. 367-377(11)
Authors: Chen, George G.; Vlantis, Alexander C.; Zeng, Qiang; van Hasselt, C. A.

Novel Epigenetic Targets in Lymphoproliferative Disorders
pp. 378-391(14)
Author: Delgado, Julio

Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
pp. 392-403(12)
Authors: Amir, Ethan; Hughes, Sarah; Blackhall, Fiona; Thatcher, Nick; Ostoros, Gyula; Timar, Jozsef; Tovari, Jozsef; Kovacs, Gabor; Dome, Balazs

Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy
pp. 414-420(7)
Authors: Gradilone, A.; Pulcinelli, F. M.; Lotti, L. V.; Trifiro, E.; Martino, S.; Gandini, O.; Gianni, W.; Frati, L.; Agliano, A. M.; Gazzaniga, P.

NUPR1 Interacts with p53, Transcriptionally Regulates p21 and Rescues Breast Epithelial Cells from Doxorubicin-Induced Genotoxic Stress
pp. 421-430(10)
Authors: Clark, David W.; Mitra, Aparna; Fillmore, Rebecca A.; Jiang, Wen G.; Samant, Rajeev S.; Fodstad, Oystein; Shevde, Lalita A.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page